Sentences with phrase «on assistance programs»

«The pious protestations to the contrary, Ronald Reagan has stayed his course on education — and his course has been the deliberate assault on assistance programs for the handicapped, the disadvantaged, and those persons who have suffered discrimination for decades — female students and those who don't speak English as a first language,» said Charles T. Manatt, chairman of the Democratic Party organization.

Not exact matches

More uniquely, Paychex also offers an on - site assistance program that puts HR professionals in the office when customers need more help.

If an employee participates in the assistance program and returns to work, the focus should be on continued recovery and easing back into work duties.

The reference to «end of the program» means June, though the financial assistance to Greece comes to an end on August 20.

Although Marathon has insisted that the $ 89,000 burden won't be sloughed on to patients after discounts, rebates, and assistance programs, Aronin declared a temporary ceasefire on Monday.

It is no secret that programs directed at employee engagement, leadership development, wellness, and employee assistance all show a significant return - on - investment for employers.

The budget also proposes to spend $ 80 million on a new three - year Industrial Research Assistance Program that will help colleges partner with small and medium enterprises on projects that relate to new information and communication technologies.

I attended the New York City program, which is co-sponsored by a city business - assistance service and is coming up on its 1,000 th graduate.

The same outside adviser, who was unidentified in Tuesday's release, advised that a package of assistance programs to patients would: «force reporters to focus on the byzantine nature of drug pricing and health care and ensure the patient message gets out... specifically tie profits from Daraprim to the research and development of a new and more effective treatment for Daraprim patients.

«The Department of State's foreign assistance programs are rigorously designed, implemented, and monitored to ensure that they are based on core American values,» MacManus said in a letter.

The Defense Loan and Technical Assistance (DELTA) Program was implemented to help ease the impact of national defense cuts on defense - dependent small businesses.

Fifty - nine percent of respondents supported Hillary Clinton's plan, which includes the individual mandate, when informed that the plan also includes government assistance for those who need it, requirements on employers to play or pay, and increased government programs.

You have to, then, blame policy, and the fundamental policy approach over the past five years has been to spend more on social programs and government assistance, all at the cost of America's businesses, the small business owners and our most successful earners.

When the Administration couldn't kill the program outright, it proposed to eliminate funding for technical assistance to these most fragile of borrowers by raising the fees on their loans, but Congress balked.

It may have to do with Addyi's high pricing (on par with Viagra at $ 26 per pill without an assistance program), its daily intake requirement (unlike Viagra, it adds up to $ 780 per month), its potentially deleterious side effects (low blood pressure and fainting), its restrictions on alcohol consumption (abstinence vs. large quantities not recommended for Viagra patients), a 10 % efficacy rate (whereas Viagra works 50 % of the time compared to a placebo, according to a recent study), and its subtle neurotransmitter - targeting mechanism (contrast that to the obvious hydraulics of Viagra).

Programs like parental leave, sabbaticals, and adoption assistance are the cherry on top.

According to the Center on Budget and Policy Priorities, a nonpartisan research group that focuses on reducing poverty, 20 million children in the United States (nearly 1 in 4) will have received Supplemental Nutrition Assistance Program (SNAP) benefits — better known as food stamps — in 2016.

And he built on that concept on Thursday, announcing that his firm will bolster its patient assistance programs for more than 40 drugs, including by helping people who make up to four times the federal poverty level buy their treatments for free.

It requires that «no person in the United States shall, on the basis of sex, be excluded from participation in, be denied the benefits of, or be subjected to discrimination under any education program or activity receiving federal financial assistance.»

While the drug maker has responded to the massive backlash over its extravagant price increase on the device by boosting its patient assistance programs and introducing an authorized generic EpiPen version at half the cost, CVS» topline price will still be significantly cheaper.

Shares of Dollar Tree Inc. and Dollar General Corp. both dropped on Monday after President Donald Trump unveiled the plan, which would slash cash payments and substitute them with packages of food — potentially one of the biggest shake - ups in the history of the Supplemental Nutrition Assistance Program, or SNAP.

Trump signed the Reducing Poverty in America by Promoting Opportunity and Economic Mobility executive order on Tuesday, directing federal agencies to expand work requirements for those who receive benefits from government assistance programs such as Medicaid, SNAP, and public housing.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tPrograms (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (tprograms; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Amazon halts an expansion effort in its hometown as the Seattle City Council prepares to vote on a new tax that would be levied on large business to pay for affordable housing and homeless - assistance programs.

Protecting major transfers to persons, spending on health and education and other spending such as that for Aboriginal programs, research and development, and assuming you won't revisit defense and international assistance, then to find an additional $ 8 to $ 11 billion by 2015 - 16 would require major cuts in labor market programs, spending on the homeless, infrastructure programs, and last, but certainly not least, government personnel costs.

UMSL, Gateway Accelerate and all program partners may provide advice or assistance on specific matters upon request, but business decisions will be made solely by the entrepreneur's company management.

(The Federal Housing Administration has estimated that losses on mortgages that relied on seller - funded down payment assistance programs funded by homebuilders may end up costing FHA more than $ 15 billion).

Focused on what is normally termed the «pre-commercial» phase, before a new product is broadly available on the market, the «Commercialization Research and Preparedness Assistance (CRPA) Program would provide support to companies for innovation in commercialization and market preparedness measures to achieve higher levels of business success.

Whereas the existing Industrial Research Assistance program (IRAP) would be focused on helping companies achieve a higher level of technology and management readiness, the CRPA Program would help them achieve commercial readiness for actual business sprogram (IRAP) would be focused on helping companies achieve a higher level of technology and management readiness, the CRPA Program would help them achieve commercial readiness for actual business sProgram would help them achieve commercial readiness for actual business success.

However, unlike the present «pilot» program which invites all companies with any new pre-commercial product to apply for its innovation to be trialled within government, the CICP should catalyze Canadian competitiveness through «smart assistance» by focusing on addressing the identified future needs of government agencies and departments through closer collaboration with federal agencies and industry associations.

The EU has invested five million euros to set up a centre that provides knowledge (in - depth sector market reports, guidelines, and case studies); tailored export advice extending to legal and regulatory requirements; rules on market access and competitor and market analysis; assistance with due diligence; training programs adapted for the needs of individual companies; and hot - desks and work spaces in China.

As discussed above, the RCT on Living Goods» program includes an evaluation of the BRAC program that it has provided technical and financial assistance to.

Section 8 rental assistance programs are limited to low - income households and have proven to be effective, but the amount spent on those programs is dwarfed by the benefits received by homeowners through the mortgage interest deduction.

With the objective of learning from the rich experiences and lessons that other countries have gained from their own programs, in early 2016, the Asia Pacific Foundation of Canada announced a competitive policy research grant for research on best practices by foreign SME export assistance programs.

CMIT Solutions military veterans program includes a 20 % discount on the franchise fee, comprehensive training and launch assistance, 6 months of business coaching, and a managed marketing program for the first year.

We provide this other compensation to enhance the competitiveness of our executive compensation program and to increase the productivity (corporate aircraft travel, professional assistance with tax return preparation and financial planning), safety (security services and equipment) and health (annual physical examinations) of our executives so they can focus on producing superior financial returns for our shareowners.

From April 23 — June 7, 2018, you can share your thoughts and feedback on FEMA's draft Individual Assistance Program and Policy Guide.

Borrowers can make a down payment as low as 3 % of the cost of the property, and they may use funds from other sources (including gifts, cash on hand, and down payment assistance programs) to make the down payment.

With the tax reform debate now fully underway, Apartment List examined the popular mortgage interest deduction (MID) and compared federal expenditure on the MID to spending on Section 8 rental assistance programs.

A total and permanent disability (TPD) discharge relieves you from having to repay a William D. Ford Federal Direct Loan (Direct Loan) Program loan, Federal Family Education Loan (FFEL) Program loan, and / or Federal Perkins Loan (Perkins Loan) Program loan or complete a Teacher Education Assistance for College and Higher Education (TEACH) Grant service obligation on the basis of your total and permanent disability.

@Clark1b: Do you really believe that the gov» t should not provide programs and assistance for the needy because it infringes on the separation of church and state?

Under FEMA's Transitional Shelter Assistance (TSA) program, displaced residents and families who are still living in shelters on the island can opt to relocate to housing in Florida and New York.

In a budget request for the 2019 fiscal year titled «An American Budget,» the Trump administration is proposing not only a cut to the Supplemental Nutrition Assistance Program — known informally as food stamps — but the proposal would also keep recipients from being able to choose the majority of what they use their benefits on.

This ecological point of view underlies such international organizations as The Food and Agriculture Organization, the UN Conference on Trade and Development (and consequent establishment of a Trade Board), UNESCO, the UN Special Fund and Technical Assistance program, and others.

From church charities to foreign aid, assistance programs became acceptable only when the self - interest on all sides was clear.

All too many «pro-lifers» also have no problem being pro-war, for which our pockets seem to be bottomless, yet complain about every dime spent on programs for family planning, support for single mothers such as day care assistance, Head Start, WIC, education — things that help young single mothers and their children.

However, they disagree sharply on the outcomes by which public assistance programs should be evaluated.

This is especially great, because I'm starting a school project that involves eating for a week on the budget of someone on SNAP (Supplemental Nutritional Assistance Program... formerly known as food stamps).

As I mentioned in my last post, for a project in my community nutrition class I was challenged to eat for a week as if I were on SNAP, the Supplemental Nutrition Assistance Program (you might think of it as «food stamps»).

Within OCFT, Ms. Sasser has also served as Division Chief of Research and Policy, coordinator on combating trafficking in persons, coordinator for Executive Order 13126 list of products made with forced or indentured child labor, and project manager for technical assistance programming in South East Asia.